The acceptability of voluntary HIV antibody testing in the United States: A decade of lessons learned

AIDS

Volumn 10, Issue 14, 1996, Pages 1707-1717

  Irwin, Kathleen L ^a   Valdiserri, Ronald O ^a   Holmberg, Scott D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

AIDS serodiagnosis; Mass screening; Patient acceptance of health care

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MASS SCREENING; PATIENT COUNSELING; PRIORITY JOURNAL; SERODIAGNOSIS; UNITED STATES;

EID: 0029853707     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199612000-00016     Document Type: Article

References (103)

1. Centers for Disease Control Advisory Committee on the Prevention of HIV Infection: External Review of CDC's HIV Prevention Strategies. Final Report. June 1994. Atlanta: CDC; 1994.
2. Schoenborn C, Marsh S, Hardy A: AIDS Knowledge and Attitudes for 1992: Data from The National Health Interview Survey. Advance Data from Vital and Health Statistics. No. 243. Hyattsville: National Center for Health Statistics; 1994 [PHS no. 94-1250].
3. Centers for Disease Control: HIV counseling and testing services from public and private providers - United States, 1990. MMWR 1992, 40:743,749-752.
4. Berrios DC, Hearst N, Coates TJ, et al.: HIV antibody testing among those at risk for infection: The National AIDS Behavioral Surveys. JAMA 1993, 270:1576-1580.
5. Centers for Disease Control: Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987, 36:509-515.
6. Centers for Disease Control and Prevention: Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. MMWR 1993, 42 (RR-2):1-6.
7. Centers for Disease Control and Prevention: US Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR 1995, 44 (RR-7):1-15.
8. Institute of Medicine, Committee on Prenatal and New Born Screening tor HIV Infection: HIV Screening in Pregnant Women and Newborns. Edited by Hardy LM. Washington, DC: National Academy Press; 1991.
9. National AIDS Commission: Preventing HIV Transmission in Health Care Settings. Eighth Interim Report to the President and the Congress. July 1992. Washington, DC: National AIDS Commission; 1992.
10. American Medical Association. Department of HIV: Digest of HIV/AIDS Policy. Chicago: American Medical Association; 1994.
11. American College of Physicians and Infectious Diseases Society of America: Human immunodeficiency virus (HIV) infection [position paper]. Ann Intern Med 1994, 120:310-319.
12. American College of Obstetricians and Gynecologists: Human Immunodeficiency Virus Infections. [Technical Bulletin No. 165]. Washington, DC: American College of Obstetricians and Gynecologists; 1992.
13. Anderson JE, Hardy AM, Campbell CH: Counseling and testing services in the US: public and private providers. VIII International Conference on AIDS. Amsterdam, July 1992 [abstract PoC4541].
14. Bamji M, Gupta V, Isoub S, Inamdar S: Factors predicting refusal to be tested for HIV antibody and failure to obtain results. Presented at the 120th Annual Meeting of the American Public Health Association. Washington, DC, November 1992.
15. Lindsay MK, Peterson HB, Willis S, et al.: Incidence and prevalence of human immunodeficiency virus infection in a prenatal population undergoing routine voluntary human immunodeficiency virus screening, July 1987 to June 1990. Am J Obstet Gynecol 1991, 165:961-964.
16. Lindsay MK, Feng TI, Peterson HB, Slade BA, Willis S, Klein L: Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients. Obstet Gynecol 1991, 77:599-603.
17. Barbacci M, Repke JT, Chaisson RE: Routine prenatal screening for HIV infection. Lancet 1991, 337:709-711.
18. Krasinski K, Borkowsky W, Bebenroth D, Moore T: Failure of voluntary testing for HIV to identify infected parturient women in a high-risk population [letter]. N Engl J Med 1988, 318:185.
19. Hull HF, Bettinger CJ, Gallaher MM, Keller NM, Wilson J, Mertz GJ: Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. JAMA 1988, 260:935-938.
20. Mostashari F, Altice FL, Singh R, Selwyn PA: Anonymous but linked HIV testing of male prisoners in Connecticut. X International Conference on AIDS. Yokohama, August 1994 [abstract PC0324].
21. Groseclose SL, Erickson B, Quinn TC, Glasser D, Campbell CH, Hook EW: Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public sexually transmitted disease clinics. Sex Transm Dis 1994, 21:31-35.
22. Hirsch MS, D'Aquila RT: Therapy for human immunodeficiency virus infection. N Engl J Med 1993, 328:1686-1695.
23. Higgins DL, Galavotti G, O'Reilly KR, et al.: Evidence for the effects of HIV antibody counseling and testing on risk behavior. JAMA 1991, 266:2419-2429.
24. Holtgrave DR, Valdiserri RO, Gerber R, Hinman AR: Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis. Arch Intern Med 1993, 153:1225-1230.
25. Ciesielski CA, Bell DM, Marianos DW: Transmission of HIV from infected health care workers to patients. AIDS 1991, 5 (suppl 2):S93-S97.
26. Henderson DK, Fahey BJ, Willy M, et al.: Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med 1990, 113:740-746.
27. World Health Organization: Current And Future Dimensions Of The HIV/AIDS Pandemic. September 1990. Geneva: WHO, GPA; 1990.
28. George JR, Schochetman G: Detection of HIV infection using serologic techniques. In AIDS Testing. Edited by George JR, Schochetman G. New York: Springer-Verlag; 1994:62-102.
29. Lee JH, Branan L, Watkins L, Hoff GL, Bayer WL, Tegtmeir G: Voluntary human immunodeficiency virus testing: acceptance levels and identification of seropositive individuals. South Med J 1991, 84:198-199.
30. Jaccard J, Endias R, Minkoff H: Psychosocial factors influencing HIV testing. VI International Conference on AIDS. San Francisco, June 1990 [abstract ThD837].
31. Sorin MD, Tesoriero J, McCullough ML: Correlates of acceptance of HIV testing and post-test counseling in the obstetrical setting. AIDS Educ Prev 1996, 8:72-85.
32. Valdiserri RO, Moore M, Gerber AR, Campbell CH, Dillon BA, West GR: A study of clients returning for counseling after HIV testing: implications for improving rates of return. Public Health Rep 1993, 109:12-18.
33. Healton C, Messeri P, Howard J, Abramson D, Bayer R: HIV Counseling And Testing In New York State Family Planning And Prenatal Care Assistance Programs. Albany: New York State Department of Health, AIDS Institute; 1994.
34. Weinstein ND: Testing four competing theories of health-protective behavior. Health Psychol 1993, 12:324-333.
35. Jones JL, Hutto P, Meyer P, Dowda H, Gamble WB, Gunn RA: HIV seroprevalence and reasons for refusing and accepting HIV testing. Sex Transm Dis 1993, 20:334-337.
36. Werner B, Eastman E, Salter J, Etkind P, Demaria A, Timperi R: Reasons for refusing HIV counseling and testing at urban STD clinic. II National Conference on Human Retroviruses and Related Infections. Washington, DC, January-February 1995 [abstract 594].
37. Killian H, Risi G, James D, Muirhead L, Shields J, Marier R: HIV infection rates in parturients who receive no prenatal care. V International Conference on AIDS. Montreal, June 1989 [abstract B504].
38. Harrison WO, Moore TA: Prenatal HIV screening in a low-risk population. IV International Conference on AIDS. Stockholm, June 1988 [abstract 4630].
39. McFarland L, Dean H, Trahan B, Muirhead L: HIV infection in pregnant women at a public hospital in New Orleans, Louisiana. V International Conference on AIDS. Montreal, June 1989 [abstract WAP8].
40. Barton JJ, O'Connor TM, Cannon MJ, Weldon-Linne CM: Prevalence of human immunodeficiency virus in a general prenatal population. Am J Obstet Gynecol 1989, 160:1316-1324.
41. Cozen W, Mascola L, Enguidanos R, et al.: Screening for HIV and hepatitis B virus in Los Angeles County prenatal clinics. J Acquir Immune Defic Syndr 1993, 6:95-98.
42. LaGuardia K, McGuinness K, Greene M, Dando H, Natale A: Universal HIV counseling in a prenatal population. VII International Conference on AIDS. Florence, June 1991 [abstract MC3334].
43. Holman S, Minkoff H, Hoegsberg B, Beller F, Goldstein G, Landesman S: A model program for routinely offering HIV antibody testing in pregnancy. IV International Conference on AIDS. Stockholm, June 1988 [abstract 4635].
44. Holman S, Berthaud M, Sunderland A, et al.: Women infected with human immunodeficiency virus: counseling and testing during pregnancy. Semin Perinatol 1989, 13:7-15.
45. O'Campo P, Kass N, Geller G, Gielen A, Faden R: Pregnant women's attitudes about HIV testing. VI International Conference on AIDS. San Francisco, June 1990 [abstract ThD803].
46. Lindsay MK, Adefris A, Peterson HB, Williams H, Johnson J, Klein L: Determinants of acceptance of routine voluntary human immunodeficiency virus testing in an inner-city prenatal population. Obstet Gynecol 1991, 78:678-680.
47. Minkoff HL, Holman S, Beller E, Delke I, Fishbone A, Landesman S: Routinely offered prenatal HIV testing [letter]. N Engl J Med 1988, 319:1018.
48. Kaunitz A, Brewer JL, Paryani SG, deSausure L, Sanchez-Ramos L, Harrington P: Prenatal care and HIV screening [letter]. JAMA 1987, 259:2693.
49. Douglas M, LaGuardia K: HIV seroprevalence rates among women tested for HIV in a department of obstetrics and gynecology: implications for more efficacious counseling and testing initiatives. IX International Conference on AIDS. Berlin, June 1993 [abstract PO-C25-3226].
50. Middleton J: Voluntary HIV-screening at the first prenatal visit. J Nurse Midwifery 1989, 34:349-351.
51. Caspe WB, Ballard C, Hand I: Post-partum HIV counseling in a high-risk population. VIII International Conference on AIDS. Amsterdam, July 1992 [abstract PoC4809].
52. Limata C, Cohen D, Black S, Schoen E: Compliance with voluntary prenatal testing for human immunodeficiency virus (HIV). XI National Neonatal Screening Symposium. Corpus Christi, TX, September 1994 [abstract O13].
53. Jackson J, Frederick T, Mascola L: Five years of successful prenatal HIV screening in Los Angeles County: a pilot for the Nation. Second National Conference on Human Retroviruses and Related Infections. Washington, DC, January-February 1995 [abstract 567].
54. Holman S, Sorin MD, Crossette J, LaChance-McCullough ML: A state program for postpartum HIV counseling and testing. Public Health Rep 1994, 109:521-529.
55. Santana W, Williams NM, Kline A, McNally K, Goff H: Response of prenatal clinic populations to voluntary HIV education and testing. VI International Conference on AIDS. San Francisco, June 1990 [abstract SC666].
56. Fehrs LJ, Hill D, Kerndt PR, Rose TP, Henneman C: Targeted HIV screening at a Los Angeles prenatal/family planning health center. Am J Public Health 1991, 81:619-622.
57. Hill D, Rose T, Kerndt PR: Racial differences in risk behavior, contraceptive use and HIV serprevalence among women in family planning clinics in Los Angeles County. VI International Conference on AIDS. San Francisco, June 1990 [abstract FC731].
58. Miller KS, Hennessy M, Wendell DA, Webber MP, Schoenbaum EE: Behavioral risks for HIV infection associated with HIV testing decisions. AIDS Educ Prev 1996, 8:394-402.
59. Lindsay M, Grant J, Slade B, et al.: Human immunodeficiency virus infection among patients in a gynecology emergency department. Obstet Gynecol 1993, 81:1012-1015.
60. Dottino PR, Sperling R, Kee R: Screening for human immunodeficiency virus and sexually transmitted disease in an inner-city colposcopy clinic. Mt Sinai J Med 1993, 60:327-329.
61. Hoegsberg B, Abulafia O, Sedlis A, et al.: Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease. Am J Obstet Gynecol 1990, 163:1135-1139.
62. Sperling RS, Sacks HS, Mayer L, loyner N, Berkowitz RL: Umbilical cord blood serosurvey for HIV in parturient women in a voluntary hospital in New York City. Obstet Gynecol 1989, 73:179-181.
63. Beidas S, LoConte J, Byrnes D: Anonymous or confidential HIV testing at STD clinics. V International Conference on AIDS. Montreal, June 1989 [abstract E713].
64. Bolan G, Kellogg TA, Geoghegan C, et al.: Comparison of HIV seroprevalence methodologies in a high prevalence population: blinded and non-blinded surveys in a sexually transmitted disease clinic. VI International Conference on AIDS. San Francisco, June 1990 [abstract FC683].
65. Borden LS, Wood RC, Hoffman RE, Mostrow SR, Simms CW: Characteristics of a high risk population refusing routine confidential HIV testing offered in a sexually transmitted disease (STD) clinic. VI International Conference on AIDS. San Francisco, June 1990 [abstract SC674].
66. Erickson B, Wasserheit JN, Rompalo AM, Brathwaite W, Glasser D, Hook EW: Routine voluntary HIV screening in STD clinic clients: characterization of infected clients. Sex Transm Dis 1990, 17:194-199.
67. Fleming D, Bennett D, Klockner R, Gould J, Cassidy D, Foster L: HIV infected STD clients who decline HIV counseling and testing. V International Conference on AIDS. Montreal, June 1989 [abstract MAO22].
68. Ford W, Kerndt PR, Rose TP, Nahlen BL: Comparison of acceptors and refusers of confidential HIV testing among patients in sexually transmitted disease clinics in Los Angeles County. VI International Conference on AIDS. San Francisco, June 1990 [abstract SC673].
69. DiFernando G, Chang H, Morse D, Murphy D, Tobey E: HIV counseling and testing in New York State (NYS) sexually transmitted disease (STD) clinics. V International Conference on AIDS. Montreal, June 1989 [abstract WDP15].
70. Sullivan C, Henry K, Sonnen M, Bilek L: Varying rates of voluntary HIV testing among high-risk groups at a public sexually transmitted disease clinic. IX International Conference on AIDS. Berlin, June 1993 [abstract PO-C20-3086].
71. Schwarcz SK, Bolan GA, KelloggTA, Kohn R, Lemp GF: Comparison of voluntary and blinded human immunodeficiency virus type 1 (HIV-1) seroprevalence surveys in a high prevalence sexually transmitted disease clinic population. Am J Epidemiol 1993, 137:600-608.
72. Wenger NS, Linn LS, Epstein M, Shapiro MF: Reduction of high-risk sexual behavior among heterosexuals undergoing HIV antibody testing: a randomized clinical trial. Am J Public Health 1991, 81:1580-1585.
73. Magura S, Grossman JI, Lipton DS, Amann KR, Koger J, Gehan K: Correlates of participation in AIDS education and HIV antibody testing by methadone patients. Public Health Rep 1989, 104:231-240.
74. Marlink RG, Foss B, Swift B, Davis B, Essex M: High rate of HTLV-III/HIV exposure in IVDA's from a small-sized city and the failure of specialized methadone maintenance to prevent further drug use. J International Conference on AIDS. Washington, DC, June 1987 [abstract Th5.1].
75. Carlson GA, McClellan TA: The voluntary acceptance of HIV-antibody screening by intravenous drug users. Public Health Rep 1987, 102:391-394.
76. Reardon J, Warren N, Keilch R, Jenssen D, Wise F, Brunner W: Are HIV-infected injection drug users taking HIV tests? Am J Public Health 1993, 83:1414-1417.
77. McCusker J, Bigelow C, Zapka JG, Zorn M, Stoddard AM, Lewis BF: HIV-1 antibody testing among drug users participating in AIDS education. Patient Educ Counsel 1994, 24:267-278.
78. Liebman J, Mcllvaine DS, Kotranski L, Lewis R: AIDS prevention for IV drug users and their sexual partners in Philadelphia. Am J Public Health 1990, 80:615-616.
79. Sherer R, Cohen G, Cohen M, Pulvirenti J, Albrecht GL, Zalenski R: HIV counseling and testing among 15,000 inner city minority patients at Cook County Hospital from 1987-1992. IX International Conference on AIDS. Berlin, June 1993 [abstract PO-C25-3208].
80. Decantis ML, DeBuono B, Scott HD: Routine HIV testing in an acute care hospital inpatient setting. VI International Conference on AIDS. San Francisco, June 1990 [abstract ThD826].
81. Cadena R, Cabrera I, Cohen M, et al.: A three year comparison of demographic trends of clients receiving HIV antibody testing and counseling at Cook County Hospital, Chicago. VI International Conference on AIDS. San Francisco, June 1990 [abstract SC6].
82. Harris RL, Boisaubin EV, Salyer PD, Semands DF: Evaluation of a hospital admission HIV antibody voluntary screening program. Infect Control Hosp Epidemiol 1990, 11:628-634.
83. Hoxie NJ, Vergeront JM, Frisby HR, Pfister JR, Golubjatnikov R, Davis JP: HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin. Am J Public Health 1990, 80:1129-1131.
84. Andrus JK, Fleming DW, Knox C, et al.: HIV testing in prisoners: is mandatory testing mandatory? Am J Public Health 1989, 79:840-842.
85. Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D: Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol 1994, 139:918-926.
86. Mantell JE, Tross S, Rapkin B, et al.: Determinants of the decision to seek HIV testing among inner city women. VIII International Conference on AIDS. Amsterdam, July 1992 [abstract PoC4826].
87. Gorman EM, Yano E, Kanouse D, Berry S, Bye L: Decision-making about HIV antibody testing among gay and bisexual men and the general population in Los Angeles. VI International Conference on AIDS. San Francisco, June 1990 [abstract ThD835].
88. Melroe H, Goodroad B, Campbell S, Henry K: Attitudes of health care workers toward being tested/monitored for HIV infection. IX International Conference on AIDS. Berlin, June 1993 [abstract PO-C18-3028].
89. Stein MD, Flanigan TP, Carpenter CCJ, et al.: The changing presentation of HIV disease in women in Rhode Island. J Women's Health 1993, 2:367-371.
90. Cohn DL, Miller LA, Yamaguchi KJ, Douglas JM: Denver's increase in HIV counseling after Magic Johnson's HIV disclosure [letter]. Am J Public Health 1992, 82:1692.
91. Leslie J, Wettrich M, Dillon B: HIV testing patterns for persons presenting to STD clinics by gender and select client risk behavior - US 1991. IX International Conference on AIDS. Berlin, June 1993 [abstract PO-C25-3222].
92. Fordyce EJ, Sambula S, Stoneburner R: Mandatory reporting of human immunodeficiency virus testing would deter blacks and Hispanics from being testing [letter]. JAMA 1989, 262:349.
93. Kassler WJ, Meriwether R, Blackenship E, et al.: Anonymous vs. confidential HIV testing in North Carolina. VIII International Conference on AIDS. Amsterdam, July 1992 [abstract PoC4818].
94. Hoffman R, Cohn D, Toxworth T, et al.: Comparison of anonymous and confidential HIV test sites: Colorado, 1990-1992. IX International Conference on AIDS. Berlin, June 1993 [abstract PO-C30-3272].
95. Zimmerman RS, Langer LM: Final report. STD Prevention Planning Project. February 1993. Prepared for the CDC and the State of Florida Department of Health and Rehabilitative Services. Miami: University of Miami; 1993.
96. Macro International, Inc.: Assessment of CDC-Funded Counseling, Testing, Referral, and Partner Notification (CTRPN) Services for Prevention of HIV Transmission. Report to Centers for Disease Control. March 31, 1992. Bettsville: Macro International; 1992.
97. Centers for Disease Control and Prevention: Technical guidance on HIV counseling. MMWR 1993, 42 (RR-2):11-7.
98. Capkin M, Phipps I, Peacock E: Ensuring patient consent for HIV testing: an evaluation of the impact of policy on practice. VI International Conference on AIDS. San Francisco, June 1990 [abstract ThD825].
99. Field MA: Testing for AIDS: uses and abuses. Am J Law Med 1990, 16:33-106.
100. Johnson WD, Sy FS, Miller JP: A comparison of alternate test site attendance in two cities under different HIV reporting policies. VI International Conference on AIDS. San Francisco, June 1990 [abstract ThD823].
101. Kassler WJ, Dillon B, Haley C, et al.: HIV prevention counseling using an on-site, rapid HIV assay. X International Conference on AIDS. Yokohama, August 1994 [abstract 518B/D].
102. Shippee D, Neville JM, Johnson MJ: Comparison of participants in differing anonymous HIV testing and counseling settings. IX International Conference on AIDS. Berlin, June 1993 [abstract PO-C25-3213].
103. American Medical Association Board of Trustees: Prevention and control of acquired immunodeficiency syndrome: an interim report. JAMA 1987, 258:2097-2103.